Researchers publish critical examination of new brain tumor drug

Two researchers from the Icahn School of Medicine at Mount Sinai recently published their critical evaluation of a new brain tumor medicine in the journal Nature Reviews Clinical Oncology.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup